# Reig Jofre

> Reig Jofre is a VC fund in Barcelona backing Medical and Pharmaceutical. See 2 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Barcelona, Spain
- Total investments: 2
- Last investment: Feb 2024
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/laboratorio-reig-jofre/
- Website: http://www.reigjofre.com/

Reig Jofre is a manufacturer of pharmaceutical products. The company produces drugs, penicillin antibiotics, and other pharmaceutical products.

## Contacts

5 contacts available for Reig Jofre. Shizune tracks 2 team members at Reig Jofre. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/reig-jofre?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 2 | 100% |
| Pharmaceutical | 2 | 100% |
| Biopharma | 1 | 50% |
| Life Science | 1 | 50% |
| Biotechnology | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 50% |
| Venture - Series Unknown | 1 | 50% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Ignasi Biosca | Chief Executive Officer | 0 | https://shizune.co/investors/profile/ignasi-biosca |
| Jordi Gonzalez Plagaro | Director of Research and Development | 0 | https://shizune.co/investors/profile/jordi-gonzalez-plagaro |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Affirma Biotech | Affirma Biotech is a developer of host-directed drugs as broad-spectrum treatments for chronic and severe infectious diseases. The company utilizes host-directed therapy strategies to interfere with host cell factors that are required by a pathogen for replication or persistence. The company engages in the discovery and development of newanti-infective drugs via immunomodulation. | $1.9M | Venture - Series Unknown | Feb 01, 2024 |  |
| Vaxdyn | Vaxdyn develops vaccines using novel technology. They offers pathogen vaccines for preventing antibiotics-resistant infections. Their customers' inquiries are addressed through phone, email, and online applications. | $355.5K | Seed | Mar 08, 2021 |  |

2 of 2 investments shown.

## Co-investors
- [Bionova Capital](https://shizune.co/investors/profile/hovione-capital) — VC Fund, 2 deals together
- [Arquimea Ingeniera](https://shizune.co/investors/profile/arquimea-ingeniera) — VC Fund, 1 deal together
- [BCN PEPTIDES](https://shizune.co/investors/profile/bcn-peptides) — VC Fund, 1 deal together
- [Capital Cell](https://shizune.co/investors/profile/capital-cell) — VC Fund, 1 deal together
- [Fundacion Botin](https://shizune.co/investors/profile/fundacion-botin) — VC Fund, 1 deal together
- [GENESIS Biomed](https://shizune.co/investors/profile/genesis-biomed) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [ENISA](https://shizune.co/investors/profile/enisa-2) — VC Fund
- [Inveready](https://shizune.co/investors/profile/inveready-technology-investment-group) — VC Fund
- [Angels Capital](https://shizune.co/investors/profile/angels-capital) — VC Fund

## Featured in investor lists
- [Medical Investors in Spain](https://shizune.co/investors/medical-investors-spain)
- [Medical VC Funds in Spain](https://shizune.co/investors/medical-vc-funds-spain)
- [Life Science Investors in Spain](https://shizune.co/investors/life-science-investors-spain)

## FAQ

### What does Reig Jofre invest in?

Reig Jofre invests primarily in Medical, Pharmaceutical and Biopharma startups, most often at Seed and Venture - Series Unknown stage. Most of the 2 investments tracked by Shizune back companies in Spain. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Reig Jofre?

Public channels for Reig Jofre include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Reig Jofre?

The team at Reig Jofre includes Ignasi Biosca (Chief Executive Officer) and Jordi Gonzalez Plagaro (Director of Research and Development). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co